NCT00637741

DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

Physician Initiated Trial Investigating the Efficacy of the Implant of EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Flanders Medical Research Program · Network
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this clinical investigation is to evaluate the long-term (up to 12 months) outcome of the 200 mm long self-expanding nitinol EverFlex (ev3) stent in long femoropopliteal lesions (TASC C \& D) Is is the first time that the use of 200 mm long stents will be evaluated in these lesions. It is expected that the outcome of the treatment with this type of long stents will be better as the treatment of identical lesions lengths with multiple shorter stents.

Conditions

• Peripheral Vascular Disease
• Intermittent Claudication
• Critical Limb Ischemia

Interventions

Type	Name	Description
DEVICE	Everflex 200

Timeline

• Start date: 2008-03-01
• Primary completion: 2009-09-01
• Completion: 2010-11-01
• First posted: 2008-03-18
• Last updated: 2010-12-01

Locations

2 sites across 1 country: Belgium